ArticleInternational journal of fertility & sterility2025
Investigation of The Effect of Myomectomy on Anti-Mullerian Hormone Level in Women with Uterine Leiomyoma: A Prospective Quasi-Experimental Study.
Article in International journal of fertility & sterility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Myomectomy is commonly performed on women diagnosed with symptomatic uterine leiomyoma(s). This study aimed to evaluate the effects of myomectomy on the serum anti-Müllerian hormone (AMH) levels in women with uterine myoma. Materials and Methods: In this prospective quasi-experimental study, 93 patients with uterine leiomyoma aged 18- 45 years were enrolled and underwent open and laparoscopic myomectomy. The participants' baseline characteristics were recorded. The level of AMH was measured and recorded before and six months after the surgery for each patient. The size, number, and type of myoma, the duration of surgery, the volume of bleeding during surgery, the need for blood transfusion, and postsurgical complications were investigated at 6-month intervals after the surgery. Data were analyzed by SPSS version 26. Results: The AMH level decreased significantly after the surgery compared to before the surgery in both groups of laparotomic and laparoscopic myomectomy patients (P<0.001). The rate of AMH drop was lower in the laparoscopy group than in the laparotomy group (P<0.001). Among the studied variables, changes in AMH level showed a direct and significant correlation with myoma size and type. Postoperative pain, fever, and surgical site infection (SSI) were the most frequent postsurgical complications. In post-surgical period, fever rate was 12.3% in the laparotomy group, and 6.1% in the laparoscopy group, and pain (measured by visual analogue scale) was higher in the laparotomy group compared to the laparoscopy group (21 vs. 7.3%). SSI rate was 0.9% in the laparoscopy group compared to 6.3% in the laparotomy group. The size of the myoma had no significant effect on the occurrence of these complications. Conclusion: Myomectomy may lead to a significant decrease in AMH levels in women with uterine leiomyoma undergoing both open and laparoscopic myomectomies, and the size and type of myoma significantly affects the changes in the hormone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.